Activation of an AKT/FOXM1/STMN1 pathway drives resistance...

  • Main
  • 2017 / 08
  • Activation of an AKT/FOXM1/STMN1 pathway drives resistance...

Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer

Li, Meng, Yang, Jingyu, Zhou, Wenlong, Ren, Yong, Wang, Xiaoxuan, Chen, Huiping, Zhang, Jingyuan, Chen, Junli, Sun, Yuhong, Cui, Lijuan, Liu, Xing, Wang, Lihui, Wu, Chunfu
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2017.292
Date:
August, 2017
File:
PDF, 2.52 MB
english, 2017
Conversion to is in progress
Conversion to is failed